Treating critically ill patients with probiotics: Beneficial or dangerous?

被引：26

作者：

Jacobi, Christoph A. ^{[1
]}

Schulz, Christian ^{[1
]}

Malfertheiner, Peter ^{[1
]}

机构：

[1] Univ Klinikum Magdeburg, Klin Gastroenterol Hepatol & Infektiol, D-39120 Magdeburg, Germany

来源：

GUT PATHOGENS | 2011年 / 3卷

关键词：

VENTILATOR-ASSOCIATED PNEUMONIA; EARLY ENTERAL NUTRITION; GUT BARRIER FUNCTION; DOUBLE-BLIND; LACTOBACILLUS; THERAPY; BIFIDOBACTERIUM; SYNBIOTICS; PREVENTION; SEPSIS;

D O I：

10.1186/1757-4749-3-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Probiotic bacteria are live microorganisms which confer to health benefits of the host. They help to maintain the integrity of the intestinal barrier function by modulating the mucosal and systemic immune response of the host. These bacteria have proven their beneficial effect in several conditions of ulcerative colitis. More recently probiotics/synbiotics have been included in the treatment of critically ill patients. However to date it remains uncertain whether probiotics/synbiotics are beneficial or even dangerous to the clinical outcome of this patient group. This article reviews the current evidence of the use of bacteria in critically ill patients in intensive care settings.

引用

页数：5

共 24 条

[1] Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial [J].

Alberda, Cathy ;

Gramlich, Leah ;

Meddings, Jon ;

Field, Catherine ;

McCargar, Linda ;

Kutsogiannis, Demetrios ;

Fedorak, Richard ;

Madsen, Karen .

AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 85 (03) :816-823

[2] Influence of the critically ill state on host-pathogen interactions within the intestine: Gut-derived sepsis redefined [J].

Alverdy, JC ;

Laughlin, RS ;

Wu, LC .

CRITICAL CARE MEDICINE, 2003, 31 (02) :598-607

[3]

[Anonymous], 2010, AM J RESP CRIT CARE

[4]

Barraud D, 2010, INTENSIVE CARE MED

[5] Synbiotics to strengthen gut barrier function and reduce morbidity in critically ill patients [J].

Bengmark, S .

CLINICAL NUTRITION, 2004, 23 (04) :441-445

[6] Ventilator-associated pneumonia [J].

Chastre, J ;

Fagon, JY .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) :867-903

[7] Oral probiotic and prevention of Pseudomonas aeruginosa infections:: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients [J].

Forestier, Christiane ;

Guelon, Dominique ;

Cluytens, Valerie ;

Gillart, Thierry ;

Sirot, Jacques ;

De Champs, Christophe .

CRITICAL CARE, 2008, 12 (03)

[8] DECREASE IN FREQUENCY OF LIQUID STOOL IN ENTERALLY FED CRITICALLY ILL PATIENTS GIVEN THE MULTISPECIES PROBIOTIC VSL#3: A PILOT TRIAL [J].

Frohmader, Terence J. ;

Chaboyer, Wendy P. ;

Robertson, Iain K. ;

Gowardman, John .

AMERICAN JOURNAL OF CRITICAL CARE, 2010, 19 (03) :E1-E11

[9] Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients:: A randomised controlled trial [J].

Jain, PK ;

McNaught, CE ;

Anderson, ADG ;

MacFie, J ;

Mitchell, CJ .

CLINICAL NUTRITION, 2004, 23 (04) :467-475

[10] Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics [J].

Klarin, B. ;

Wullt, M. ;

Palmquist, I. ;

Molin, G. ;

Larsson, A. ;

Jeppsson, B. .

ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2008, 52 (08) :1096-1102

← 1 2 3 →